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Hau-Ren Chen8*
Background/Purpose: Oral squamous cell carcinoma (OSCC) is an aggressive tumor and its occurrence in
Taiwan is closely related to chronic smoking, alcohol consumption, and especially to betel quid chewing. It
became the fourth most common malignant tumor of Taiwanese men in 2006. Unfortunately, there are few
biomarkers for diagnosis and treatment of this disease.
Methods: To find potential markers, two domestic cell lines (OC2 and OCSL) derived from different
grades of OSCC were established and their proteins were compared by global proteomic analysis. The ex-
pression differences of GRP78 protein in these two cell lines and clinical samples from OSCC patients were
verified.
Results: Of the 11 candidate proteins expressed differentially in both cell lines, six [heat shock protein 
90 kDa beta member 1 (94 kDa glucose-regulated protein; GRP94), protein disulfide-isomerase precursor,
vimentin, tubulin beta-2C chain, 78 kDa glucose-regulated protein precursor (GRP78), and annexin 
A2] were increased in OC2 cells (low-grade OSCC), and five (heat shock protein 90-beta, annexin A1,
stress-induced phosphoprotein 1, elongation factor-2, and integrin alpha-3 precursor) were increased 
in OCSL cells (high-grade OSCC). Some of these proteins have been previously associated with malignant
tumors, but no previous association of GRP78 with OSCC has been reported. GRP78 protein expression
in these two OSCC cell lines was confirmed by Western blotting. Immunohistochemical staining of 
clinical samples from OSCC patients revealed that decreased GRP78 protein expression was significantly
correlated with advance tumor stage (p < 0.001) and neck lymph node metastasis (p = 0.001).
Conclusion: GRP78 protein is a possible biomarker of oral cancer in Taiwan.
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Oral squamous cell carcinoma (OSCC) is a ma-
lignant disease of the oral mucosa and its occur-
rence is closely related to betel quid chewing,
chronic smoking, and alcohol consumption. In
Taiwan, the occurrence of OSCC is highly corre-
lated with betel quid chewing.1 The incidence and
severity of OSCC have been increasing. From
1999 to 2006, the mortality rates increased from
5.9 to 8.1 per 100,000 persons. In 2006, OSCC
became the fourth most common malignant
tumor in Taiwanese men.2 OSCC patients are usu-
ally treated by surgery, chemotherapy, radiother-
apy, or combined therapy.3,4 Unfortunately, the
overall 5-year survival rate is only 54.5%.5 Ad-
vanced proteomic techniques have demonstrated
that several proteins are involved in tumorigenesis
of OSCC.6,7 However, the epidemiology and patho-
genesis of OSCC differ between countries. There-
fore, previous studies from other countries might
not accurately reflect the features of OSCC in
Taiwan, where betel quid chewing is the main
epidemiological risk factor for the development
of this disease.
Prognosis and unique biomarkers related to
betel quid chewing have not been investigated
intensively; therefore, the protein profile in OSCC
of different grades in Taiwan deserves further ex-
amination. In this study, we compared the protein
profiles of normal oral mucosa and two OSCC
cell lines (OC2 and OCSL) derived from tumor
specimens of different grade in Taiwan. We char-
acterized the properties of these two cell lines and
identified 11 proteins with different expression
levels as biomarker candidates. We verified by im-
munohistochemical staining the level of 78 kDa
glucose-regulated protein precursor (GRP78) in the
cell lines by Western blotting and in specimens
from normal oral mucosa and OSCC tumors.
The results could help us to identify proteins
linked to betel quid chewing in Taiwan. The
GRP78 biomarker might also be helpful for tumor
screening, customizing treatment, detection of re-
current tumors, and understanding tumorigenesis.
Materials and Methods
Specimen preparation
This study protocol was approved by the Institu-
tional Review Board of Dalin Tzu Chi General
Hospital, Chiayi, Taiwan. The two OSCC cell lines
used in this study, OC2 and OCSL, were from buc-
cal specimens from two Taiwanese male patients
with OSCC (aged 51 and 52 years).8 Both patients
had habits of smoking, social drinking, and betel
quid chewing. The OCSL tumors were metastatic,
poorly differentiated, and resistant to chemother-
apy and radiotherapy. The cell lines were cultured
in RPMI 1640 medium with 10% heat-inactivated
fetal bovine serum and in a 5% CO2 incubator.
Morphology and immunohistochemical reac-
tivity were assessed. The standard streptavidin per-
oxidase technique using a monoclonal antibody
against cytokeratin (Clone AE1/AE3, Code M3515;
DakoCytomation, Glostrup, Denmark) was carried
out. OC2 and OCSL cell growth was evaluated
using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide assay.9
Migration (migration assay) and invasiveness
(transwell invasion assay) were also evaluated. The
assays were performed according to the manufac-
turer’s instructions (BD BioCoat™ Matrigel™, BD
Biosciences, Bedford, MA, USA). For the horizon-
tal migration assay, we performed a wound heal-
ing assay, in which the cell lines were cultured in
RPMI 1640 medium with 10% heat-inactivated
fetal bovine serum and in a 5% CO2 incubator. 
A 1-mm wound was scratched when the cells be-
came confluent on the culture plate, and refilling
of the spaces was recorded after 3 and 6 hours.
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For the vertical migration assay, the cells (2.5×104/
well) were seeded in a Millicell Cell-96 Culture
Insert (Millipore, Billerica, MA, USA). For the
transwell invasion assay, cells (2.5×104/well) were
seeded in a 6-well BioCoat Matrigel Invasion
Chamber (Beckton Dickinson, Bedford, MA, USA)
without serum, and an outer chamber that con-
tained 10% heat-inactivated fetal bovine serum
in RPMI 1640. After 24 or 48 hours incubation,
the non-invading cells were removed from the
upper surface of the membrane by scrubbing,
and the membrane was stained using hema-
toxylin and eosin. Subsequently, the invading
cells on the lower surface were counted using a
microscope (Nikon, TE-2000-U, Tokyo, Japan).
The evidence indicated that OC2 and OCSL cells
represented low and high malignancy grade
OSCCs, respectively.
Cells from the normal oral mucosa were ob-
tained in two different ways. Cells from the su-
perficial normal oral mucosa were collected by
cotton swab from the buccal mucosa of a healthy
36-year-old man. The cells were cultured under
the same conditions as the OSCC cell lines for 
3 days. Cells representing all layers of the normal
oral mucosa were derived from a surgical speci-
men from the soft palate of a healthy 39-year-old
man who underwent uvulopalatopharyngoplasty
(UPPP) surgery. The oral mucosa was selected man-
ually and placed in serum-free medium, transferred
to complete medium, and cultured under the same
conditions as OSCC cell lines for 3 days.
All cells were harvested and then lysed in lysis
buffer (7 M urea, 2 M thiourea, 100 mM dithiothre-
itol, 4% 3[(3-Cholamidopropyl)dimethylammo-
nio]-propanesulfonic acid, and 40 mM Tris–HCl
pH 8.8) that contained protease inhibitor cock-
tail (P-8340 and DNase I 1 U/mL; Sigma, St. Louis,
MO, USA) for 1 hour at 4°C using a rotator
mixer. The lysates were centrifuged at 70,000g for
10 minutes at 4°C, and the supernatants were
transferred to a new tube and ultra-centrifuged at
280,000g for 3 hours at 4°C. The supernatants
were assayed for protein concentration using the
Bio-Rad protein assay, divided into aliquots, and
stored at −80°C.
Two-dimensional (2-D) gel electrophoresis
2-D gel electrophoresis was carried out according to
manufacturer’s instructions (PROTEAN IEF Cell;
Bio-Rad, Hercules, CA, USA) and a previously de-
scribed protocol.10 Protein samples from the cell
lines (200 μg) were separated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis on Bio-
Rad 17-cm strips (pH 4–7; cat. no. 163-2008; Bio-
Rad) side by side. Each pair was repeated at least
six times to ensure reproducibility. All gels were
visualized by silver staining.10 Protein samples from
the superficial normal oral mucosa (from swab)
and full-thickness oral mucosa (from UPPP) were
also separated in parallel.
Image analysis and mass spectrometry (MS)
peptide sequencing
Images were acquired using an image scanner (GS-
800 Imaging Densitometer; Bio-Rad) and analyzed
using PD Quest software (Bio-Rad).10 Images of
OC2 and OCSL samples were analyzed in pairs
for comparison. Volume differences were normal-
ized and statistically calculated for each sample.
Spots that showed consistent and significant dif-
ferences were selected for analysis by matrix-
assisted laser desorption/ionization time-of-flight
MS. Protein spots were isolated in small pieces
and subjected to in-gel tryptic digestion overnight.10
Peptide mass spectra were recorded and parame-
ters for spectra acquisition were used as previously
described.10 The MASCOT MS/MS Ions Search
tool was used to identify proteins.11 MOWSE scores
over 50 were obtained in most cases. After analyses
showed lower mass accuracy and score matching,
the searches were repeated two or three times to
ensure accurate analysis.
Western blotting of OC2 and OCSL cell extracts
Western blotting was done to confirm the results
of proteomic analysis. Protein samples prepared
from OC2 and OCSL cell lines (separated on 10%
SDS-PAGE gels) were transferred onto polyvi-
nylidene fluoride membranes (S80306; Pall Life
Sciences, Glen Cove, NY, USA). The membranes
were soaked in a PBST blocking buffer (10 mM
phosphate buffer, pH 7.2, 150 mM NaCl, 0.5%
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Tween 20) with 5% non-fat dry milk at room tem-
perature for 30 minutes; washed with PBST; in-
cubated with anti-GRP78 antibody (sc-13968;
Santa Cruz Biotechnology, Santa Cruz, CA, USA)
at a dilution of 1:1000 for 1 hour at room temper-
ature or overnight at 4°C; washed with PBST; in-
cubated with a horseradish-peroxidase-conjugated
goat anti-rabbit IgG secondary antibody (35568
Pierce, Rockford, IL, USA) at a dilution of 1:10,000
for 1 hour at room temperature; washed exten-
sively; reacted with enhanced chemiluminescence
reagents; and analyzed using a Syngene Bio-
Imaging system (Syngene, Frederick, MD, USA).
Immunohistochemical analysis
To verify that GRP78 protein was expressed dif-
ferentially in high- and low-grade OSCCs, speci-
mens from patients with surgically resected OSCCs
and complete medical records were immunohis-
tochemically stained and analyzed for GRP78
protein. The staging and differentiation of these
tumors were recorded. Paraffin sections (5–7 μm)
were de-waxed in xylene, rehydrated in a de-
scending series of ethanol concentrations (100%
to 70%), and stained using a standard strepta-
vidin peroxidase technique that involved mono-
clonal antibody against GRP78 (sc-13968; Santa
Cruz Biotechnology). Finally, the specimens were
dehydrated in an ascending series of ethanol con-
centrations and mounted on slides for microscopic
examination. A negative control slide was prepared
using the same staining procedures except that
the primary antibody was replaced by phosphate
buffer solution. Five different fields per slide and
> 100 tumor cells per field were observed under
400× magnification. The amount of GRP78 protein
expression was graded as strong (+++), moderate
(++), and weak (+) relative to the positive control
OC2 cells (+++) and negative control OCSL (+)
cells. Correlation of the amount of GRP78 expres-
sion with clinical factors was analyzed statistically.
Statistical analysis
The data were analyzed by the paired t test and χ2
test using the SAS software package (SAS Institute,
Cary, NC, USA).
Results
Comparison of normal oral mucosa, 
OC2, and OCSL cells
Cells of the superficial normal oral mucosa were
cultured for only 3 days because they usually can-
not be cultured continuously for > 5 days. Figure
1A and 1B shows the morphology on the 1st and
3rd day, respectively. The cell lines OC2 (low 
malignancy) and OCSL (high malignancy) were
also cultured simultaneously. OC2 cells were well
differentiated and remained squamous shaped at
confluence (Figures 1C and 1D). By contrast, OCSL
cells were poorly differentiated, spindle shaped
(Figure 1E), and lacked squamous cell polarity at
confluence (Figure 1F).
Immunohistochemical staining for cytokeratin
revealed homogeneous distribution throughout
the cytoplasm of OC2 (Figure 1G) and OCSL
(Figure 1H) cells, which indicated that all the OC2
and OCSL cells were squamous. The growth curves
of the OC2 and OCSL cell lines are shown in Figure
1I. The growth rate of OCSL cell was faster than
OC2. The results of the migration assay and tran-
swell invasion assay of OC2 and OCSL cell lines
are shown in Figure 2 and Supplementary Figure 1.
The OCSL cell line had greater horizontal, verti-
cal, and transwell invasion activity than the OC2
cell line did. These results strongly suggested that
OC2 and OCSL reflected low- and high-grade
malignancy OSCC, respectively.
2-D gel electrophoresis and silver staining
Extracts from superficial normal oral mucosa,
inner normal oral mucosa (UPPP), OC2 cells, and
OCSL cells were analyzed by 2-D gel electropho-
resis using pH 4–7 IEF strips. The silver-stained
strips are shown in Figure 3. The average number
of protein spots for OC2 and OCSL cells were
around 1050 per gel, but the number for full-
thickness normal oral mucosa (from UPPP) was
only 700 per gel. Nevertheless, the distribution pat-
terns for OC2 cells, OCSL cells, and cells from the
full-thickness mucosa were similar. The distribu-
tion pattern for the superficial normal oral mu-
cosa was dramatically different from that of the
T.T. Huang, et al
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Figure 1. Cultures of various oral mucosa cells and cell lines.
Superficial normal oral mucosa cells (A) were collected from a
healthy man, and (B) cultured for 3 days. (C) Cultured cells
from the low-grade OC2 cell line and (D) were confluent after
3 days. (E) Cultured cells from the high-grade OCSL cell line
and (F) were confluent after 3 days. Immunohistochemical
staining for cytokeratin in (G) OC2 and (H) OCSL cells showed
that expression was homogeneous. (I) MTT assay showing
growth curves of OC2 (blue) and OCSL (red) cell lines. The
OCSL cell line proliferated at a higher rate.
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Figure 2. Horizontal migration, vertical migration, and transwell invasion assays of OC2 and OCSL cell lines. The OCSL
cell line had greater horizontal migration, vertical migration and transwell invasion ability than did the OC2 cell line.
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other three kinds of cells, and was not conducive
to proteomic analysis. In addition, because the
amount of full-thickness normal oral mucosa was
limited, only the OC2 and OCSL cell lines were
utilized in further proteomic analyses.
Image analysis and MS peptide sequencing
After producing at least six pairs of successful 
2-D electrophoresis gels (6 for each cell line), the
stained gels were scanned and analyzed carefully
using PDQuest software (Bio-Rad). The protein
spots that reproducibly differed in intensity be-
tween the two cell lines were identified and marked
as in Figure 4A. A total of 11 candidate spots were
identified. The pI, molecular mass, and percent-
age of the total expression for each spot are sum-
marized in Table 1. These 11 protein spots are
shown at higher magnification in Figure 4B. Spots
1–6 were upregulated in OC2 cells and downreg-
ulated in OCSL cells, whereas spots 7–11 were
downregulated in OC2 cells and upregulated in
OCSL cells. All spots were excised, subjected to in-
gel tryptic digestion, and then analyzed by matrix-
assisted laser desorption/ionization time-of-flight
MS. After searching all the data using the MAS-
COT MS/MS Ions Search engine (Supplementary
Figure 2), the candidate spots were identified as
the specific proteins listed in Table 2: spot 1, heat
shock protein 90 kDa beta member 1 (GPP94);
spot 2, protein disulfide–isomerase precursor
(PDI); spot 3, vimentin; spot 4, tubulin beta-2C
chain; spot 5, GRP78; spot 6, annexin A2; spot 7,
HSP 90-beta (HSP84); spot 8, annexin A1; spot 9,
stress-induced-phosphoprotein 1 (STI1); spot 10,
OC2 Normal oral mucosaOCSL UPPP
pH4 7 pH4 7 pH4 7 pH4 7
CA B D
Figure 3. Two-dimensional gel showing the protein profiles of the two cancer cell lines and normal oral mucosa cells.
Cell extracts were prepared from (A) OC2 cells, (B) OCSL cells, (C) superficial normal oral mucosa, and (D) full-thickness
normal oral mucosa.
OC2 OCSL
pH4 7 pH4 7
A B
OC2 OCSL
1
2 3
4
7
5
6
OC2 OCSL
8
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11
Figure 4. Identification of proteins differentially expressed in OC2 and OCSL cells. (A) Protein spots with different inten-
sities were identified and marked. Blue- and red-labeled spots represent upregulated proteins in OC2 and OCSL cells, 
respectively. (B) The 11 candidate spots at 5× magnification.
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elongation factor 2 (EF-2); spot 11, integrin alpha-
3 precursor. The calculated pI and molecular mass
of these proteins were very close to those deter-
mined experimentally from 2-D gels (Table 1).
Over 20% of the sequence of most proteins was
covered.
Western blotting of GRP78 in OC2 and
OCSL cell extracts
Some of these 11 proteins have been associated
with tumorigenesis. We focused on GRP78 be-
cause no study has reported a role for this protein
in OSCC, and in our proteomic analysis, it had
the highest sequence coverage. Western blotting
of GRP78 in OC2 and OCSL samples confirmed
that it was upregulated in OC2 extracts and down-
regulated in OCSL extracts (Figure 5).
Immunohistochemical staining of GRP78 in
OSCC tissue samples
We stained clinical samples from eight normal
individuals and 52 OSCC patients to confirm
that GRP78 expression differed between these
groups. GRP78 was expressed in the cytoplasm
in all samples. Tumor stage and extent of differ-
entiation are shown in Table 3. The results of im-
munohistochemical staining are shown in Figures
6C–E and summarized in Table 4. GRP78 was
moderately expressed in all normal oral mucosa
samples. Importantly, there were statistically signif-
icant differences in GRP78 expression between
tumor stages (p< 0.001) and between the presence
and absence of neck lymph node metastasis (p =
0.001). GRP78 was weakly expressed in OSCC sam-
ples from patients with advanced stage tumors and
neck lymph node metastasis. Consistently, GRP78
was more highly expressed in the low-grade OC2
cell line than the high-grade OCSL cell line.
Discussion
Every cell function depends on proteins directly
or indirectly, therefore, proteins that are putatively
related to tumorigenesis can theoretically be iden-
tified by analyzing their expression at different
tumor stages. In this study, we used proteomic
analysis to look for proteins that were differentially
expressed in OC2 cells, OCSL cells, superficial nor-
mal oral mucosa, and full-thickness normal oral
mucosa. The distribution of spots was similar in
OC2 cells, OCSL cells, and full-thickness normal
oral mucosa, but the number of protein spots was
lower in full-thickness normal oral mucosa than
in OC2 and OCSL cells. The distribution of spots
in superficial normal oral mucosa was totally dif-
ferent from that in the other three cell sources;
probably because the cells of superficial normal
Table 1. The 11 protein spots which were constantly different expressed between low malignant grade OC2
and high malignant grade OCSL
Protein
OC2* OCSL* 
Fold
Spot
pI
Molecular
(% total (% total 
difference†
p
Mass (kDa)
expression) expression)
1 4.8 91 2.158 ± 0.031 0.553 ± 0.079 −4 < 0.05
2 4.7 56 1.372 ± 0.052 0.101 ± 0.042 −14 < 0.01
3 4.8 56 1.902 ± 0.049 0.724 ± 0.087 −3 < 0.05
4 5.1 47 2.243 ± 0.032 0.052 ± 0.021 −43 < 0.01
5 5.1 73 0.824 ± 0.043 0.141 ± 0.072 −6 < 0.05
6 6.9 32 0.712 ± 0.029 0.113 ± 0.012 −6 < 0.05
7 5.1 82 0.152 ± 0.068 0.987 ± 0.082 +6 < 0.05
8 6.5 33 0.073 ± 0.010 1.320 ± 0.102 +6 < 0.05
9 6.6 60 0.052 ± 0.008 0.302 ± 0.042 +6 < 0.05
10 6.8 110 0.012 ± 0.003 1.302 ± 0.029 +109 < 0.01
11 7.0 18 0.241 ± 0.070 1.521 ± 0.039 +6 < 0.05
*Data presented as mean ± standard deviation; †−: downregulated in OCSL, + : upregulated in OCSL.
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Table 2. Protein identifications of the 11 protein spots
Protein 
Protein ID Name Score
Calculated pI Sequence 
spot
Mr
value coverage (%)
1 gi:119360 Endoplasmin precursor 137 92,701 4.76 13
(Heat shock protein 90 kDa 
beta member 1) (94 kDa 
glucose-regulated protein)
2 gi:2507460 Protein disulfide-isomerase 101 57,487 4.76 10
precursor (EC 5.3.4.1) 
(PDI) (Prolyl 4-hydroxylase 
beta subunit)
3 gi:55977767 Vimentin—Homo 92 53,677 5.06 27
sapiens (Human)
4 gi:55977480 Tubulin beta-2C chain 162 50,263 4.79 21
(Tubulin beta-2 chain)—
Homo sapiens
5 gi:14916999 78 kDa glucose-regulated 1370 72,404 5.07 48
protein precursor (GRP 78) 
(Heat shock 70 kDa protein 5)
6 gi:113950 Annexin A2 (Annexin II) 158 38,812 7.57 47
(Lipocortin II) (Calpactin I 
heavy chain) 
(Chromobindin-8) (p36)
7 gi:17865718 Heat shock protein  320 83,560 4.97 26
90-beta (HSP 84) 
(HSP 90)—Homo sapiens 
8 gi:113944 Annexin A1 (Annexin I) 330 38,922 6.57 39
(Lipocortin I) (Calpactin II) 
(Chromobindin-9) (p35)
9 gi:400042 Stress-induced- 60 63,237 6.40 22
phosphoprotein 1 (STI1) 
(Hsc70/Hsp90-organizing 
protein) (Hop)
10 gi:119172 Elongation factor 2 86 96,263 6.41 8
(EF-2)—Homo sapiens
11 gi:11467963 Integrin alpha-3 precursor 52 119,840 6.60 4
(P26006) (Galactoprotein B3) 
(GAPB3) (VLA-3 alpha chain)
(CD49c) (FRP-2)
oral mucosa were in stationary phase, ready-to-
be desquamated, and fully keratinized. Therefore,
our investigation focused on protein expression
differences between the low (OC2) and high
(OCSL) grade OSCC cell lines. Previously, stud-
ies have identified proteins that are differentially
expressed in normal oral mucosa and oral cancer
tissues.6,7 The tissue samples from OSCC patients
T.T. Huang, et al
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used in their analysis contained many submucosal
connective cells, muscle cells, and blood cells. In
some samples, the oral mucosa was missing,
which suggested that the difference in protein ex-
pression could not be measured accurately. Thus,
in our study, we used two cell lines established
from tumors of Taiwanese patients and normal
oral mucosal cells to represent the protein expres-
sion at different grades of malignancy. Extracts
prepared from these cell lines did not include
components of submucosal connective tissue cells,
muscle cells, and blood cells. In addition, the pro-
tein expression profile of superficial oral mucosa
was unique.
In our study, 11 candidate proteins were dif-
ferentially expressed in OSCC cell lines. Six
(GRP94, PDI, vimentin, tubulin beta-2C chain,
GRP78, and annexin A2) were upregulated in the
low-grade OC2 cell line, and five (HSP84, an-
nexin A1, STI1, EF-2 and integrin alpha-3 precur-
sor) were upregulated in the high-grade OCSL
cell line. Some of these candidate proteins have
been previously associated with malignant tu-
mors. No one has previously associated GRP78
with OSCC, therefore, we examined GRP78 ex-
pression in OSCC. The difference in GRP78 ex-
pression between OC2 and OCSL cell lines was
verified by Western blotting and immunohisto-
chemical staining. Importantly, we found that tu-
mor stage and neck lymph node metastasis were
associated with statistically significant differences
in GRP78 content. In other words, advanced
tumor stage or the presence of neck lymph node
metastasis was associated with weak expression
of GRP78, which indicates that GRP78 is weakly
expressed in the (high malignancy) OSCC cell
line (OCSL).
GRP78 is an endoplasmic reticulum (ER)
chaperone that belongs to the heat shock protein
70 (HSP) family. It has also been referred to as
immunoglobulin-heavy-chain-binding protein,
because it is involved in the folding and assembly
of newly synthesized proteins in the ER.12 In the
study of Rao et al, GRP78 increased resistance to
ER-stress-induced apoptosis.13 The relationship of
GRP78 to lung cancer has also been reported.14
72.4 kDaGRP78
Actin 42.0 kDa
OC2
10 μg
OCSL
10 μg
OC2
30 μg
OCSL
30 μg
Figure 5. Western blotting of GRP78 from OC2 and OCSL
cells. The amount of GRP78 was significantly higher in OC2
than OCSL cells. α-Actin was used as the sample-loading
control.
Table 3. Eight samples of normal oral mucosas and
52 samples of the patients of the oral
squamous cell carcinoma were selected
for immnuohistochemical staining of
GRP78 protein*
Number of patients
Tumor size 
T1 5
T2 24
T3 14
T4a 5
T4b 4
Neck lymph node metastasis
N0 28
N1 8
N2a 4
N2b 3
N2c 1
N3 8
Distant metastasis
M0 52
M1 0
Tumor stage
Stage I 5
Stage II 17
Stage III 5
Stage IVa 21
Stage IVb 4
Stage IVc 0
Tumor differentiation
Well-differentiated 6
Moderately-differentiated 37
Poorly differentiated 9
*According to American Joint Committee on Cancer Cancer Stage
Manual, 6th edition.
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A B C
OC2 (+++) OCSL (+) Normal oral mucosa-1 (++)
D
Normal oral mucosa-2 (++)
E
OSCC-1 (+++)
F
OSCC-2 (+)
Figure 6. Immunohistochemical staining of GRP78 in OC2 cells, OCSL cells, and patient samples. (A) OC2 cells showed
strong expression of GRP78 (intense brownish color). (B) OCSL cells showed weak expression of GRP78. (C and D)
Normal oral mucosa cells from two sources showed moderate expression of GRP78. OSCC specimens from some 
patients showed (E) strong expression of GRP78, whereas (F) others showed weak expression.
Table 4. Summary of the expression of GRP78 protein in OC2, OCSL cell lines, and sample from patients
using immunohistochemical staining
Clinicopathological features
Strongly (+++) Moderately (++) Weakly (+) 
p
(n = 23) (n = 17) (n = 20)
Tumor stage
Normal oral mucosa 0 6 2 < 0.001*
Stage I & II 13 7 2
Stage III & IV 10 4 16
Differentiation stage
Normal oral mucosa & 4 7 3 0.119
well differentiated
Moderately & poorly 19 10 17
differentiated
Neck LN metastasis 
Normal oral mucosa & 15 15 6 0.001*
no LN metastasis
LN metastasis 8 2 14
*Statistically significant different. LN = Lymph node.
In cancer patients, depletion of glucose and oxygen
induces a state of physiological stress in the tumor
microenvironment. To adapt to these conditions,
stress proteins including GRP78 are induced in
tumor cells. GRP78 targets mis-folded proteins for
proteasome degradation, regulates calcium homeo-
stasis, and serves as a sensor of ER stress.15 In the
present study, six of eight normal oral mucosa
samples showed moderate GRP78 expression, and
others showed weak expression. This result showed
that normal oral mucosa is not under ER stress.
Thirteen of 22 (59.1%) stage I and II OSCC sam-
ples showed strong GRP78 expression, which sug-
gested that the low-grade cancer cells probably were
under ER stress conditions. In the high-grade can-
cer, at the later stage, to overcome ER-stress-induced
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apoptosis, cancer cells develop a mechanism to
reduce the effect of ER stress. Therefore, 16/30
(53.3%) stage III and IV OSCC samples showed
weak GRP78 expression which was significantly
correlated with advanced tumor stage or neck
lymph node metastasis. The mechanism by which
advanced-stage cancer cells can overcome ER stress
is an interesting topic for further study.
Wang et al found that GRP94 and HSP70 are
highly expressed during replication of the gastric
cancer cell line BGC-823.16 Other studies found
that GRP94 interacts with other HSPs, including
GRP78.17,18 Both GRP94 and GRP78 are glyco-
proteins in the ER and function as Ca2+-dependent
chaperones. HSP84 (which represents 1–3% of
total proteins in normal cells) is overexpressed in
malignant tumors. At least one study has sug-
gested that inhibition of HSP84 could comple-
ment cancer therapy.19 Moreover, STI1, which is
upregulated in high-grade OSCL cell lines, has
also been associated with regulation of HSPs in
the heat shock response.20 At least four heat-
shock-related proteins (GRP94, GRP78, HSP84,
and STI1) were associated with OSCC in the
present study. Whether the ratio of HSPs differs
with grade of OSCC is worthy of further study.
PDI precursor was upregulated in low-grade
OC2 cells. PDI isomerizes disulfide bonds and is
important in the folding of other proteins. Pro-
teomic analysis has found that expression of PDI
precursor differs in normal lung and lung cancer
tissues.21 Further confirmation of the correlation
between OSCC grade and PDI is needed. Vimentin
is a subunit of intermediate filaments and tubu-
lin beta-2C is the major component of micro-
tubules. Both are involved in the cytoskeleton,
which is an assembly of intermediate filaments,
actin filaments, and microtubules. Vimentin is also
a mesenchymal marker. Epithelial–mesenchymal
transition is occasionally observed during tumor
progression.22 Expression of tubulin beta-2C chain
in breast cancer cell lines changes in response 
to treatment with gemcitabine.23 Tumor grade is
highly related to cytoskeletal reorganization, there-
fore, the differences in vimentin and tubulin
beta-2C chain expression between OSCC grades
implies that these proteins are potential molecu-
lar markers or targets for prognostic, diagnostic,
and therapeutic applications.
The 10 annexins (eukaryotic cell membrane
proteins) in humans are involved in membrane
transport, calcium signaling, cell proliferation,
and anti-inflammation.24 Annexin A2 mediates
the growth stimulatory effects of gastrin and 
progastrins peptides in intestinal epithelial cells
and colon cancer cells.25 Annexin A1 is upregu-
lated in head and neck cancer.26 Nuclear local-
ization of annexin A1 is also a prognostic factor
in OSCC.27 Annexins A1 and A2 were identified in
the present study. Further investigation is needed
of our finding that annexin A2 was upregulated in
the low-grade OC2 cell line and that annexin A1
was upregulated in the high-grade OCSL cell line.
EF-2 and GTP facilitate tRNA translocation dur-
ing protein synthesis.28 Proliferation of high-grade
OSCCs requires increased synthesis of proteins.
In our study, EF-2 was upregulated in the high-
grade OCSL cell line. The integrins are present in
the cell membrane and play a role in cell adhesion
and signaling. To date, 18 alpha and eight beta
subunits have been identified in humans. Integrin
αvβ6 is associated with metastasis in OSCC.29 In
the present study, integrin alpha-3 precursor was
upregulated in the high-grade OCSL cell line,
which implies that integrin alpha-3 has a putative
role in OSCC progression.
In conclusion, 11 proteins were differentially
expressed in two OSCC cell lines (one high-grade
and one low-grade). Six proteins were upregu-
lated in the low-grade OC2 cell line (GRP94, PDI,
vimentin, tubulin beta-2C chain, GRP78, and
annexin A2), and five in the high-grade OCSL
cell line (Hsp84, annexin A1, STI1, EF-2, and in-
tegrin alpha-3 precursor). Weakly expressed GRP78
was significantly correlated with advanced tumor
stage or neck lymph node metastasis. Our results
indicate that these proteins could be used in the
future as molecular markers in cancer detection
or as molecular targets in therapy. Our findings
may also help delineate possible pathways for
tumorigenesis in OSCC, especially in cases attrib-
utable to betel quid chewing in Taiwan.
GRP78 protein as a biomarker of oral cancer
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